Published in PLoS One on August 07, 2014
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? Neuropsychopharmacology (2017) 0.95
Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis. PLoS One (2015) 0.79
Changes in plasma levels of N-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis. J Diabetes Res (2015) 0.76
Exercise as an adjunctive treatment for cannabis use disorder. Am J Drug Alcohol Abuse (2016) 0.75
Dimensions of Compulsive Exercise across Eating Disorder Diagnostic Subtypes and the Validation of the Spanish Version of the Compulsive Exercise Test. Front Psychol (2016) 0.75
Modulation of Irisin and Physical Activity on Executive Functions in Obesity and Morbid obesity. Sci Rep (2016) 0.75
Physical Activity Patterns in University Students: Do They Follow the Public Health Guidelines? PLoS One (2016) 0.75
The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol (1986) 124.55
A psychobiological model of temperament and character. Arch Gen Psychiatry (1993) 10.95
Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) (2008) 9.45
A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act (2008) 7.32
Accelerometer data reduction: a comparison of four reduction algorithms on select outcome variables. Med Sci Sports Exerc (2005) 5.62
The International Prevalence Study on Physical Activity: results from 20 countries. Int J Behav Nutr Phys Act (2009) 3.99
Predicting activity energy expenditure using the Actical activity monitor. Res Q Exerc Sport (2006) 3.21
An anorexic lipid mediator regulated by feeding. Nature (2001) 2.94
Activation of the peripheral endocannabinoid system in human obesity. Diabetes (2005) 2.90
Accelerometers and pedometers: methodology and clinical application. Curr Opin Clin Nutr Metab Care (2007) 2.68
Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res (2010) 2.64
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol (2002) 2.54
A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci (2002) 2.52
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes (2006) 2.40
Accelerometer profiles of physical activity and inactivity in normal weight, overweight, and obese U.S. men and women. Int J Behav Nutr Phys Act (2010) 2.33
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) (1997) 2.31
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis. Liver Int (2009) 2.27
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl) (1999) 2.17
Personality correlates of physical activity: a review and meta-analysis. Br J Sports Med (2006) 1.95
A gut lipid messenger links excess dietary fat to dopamine deficiency. Science (2013) 1.93
The endocannabinoid system in obesity and type 2 diabetes. Diabetologia (2008) 1.61
Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology (2005) 1.49
Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biol Psychiatry (2011) 1.49
Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.44
Temperament and personality. Curr Opin Neurobiol (1994) 1.36
Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci (2011) 1.29
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia (2009) 1.28
Exercise activates the endocannabinoid system. Neuroreport (2003) 1.25
Assessment of arm activity using triaxial accelerometry in patients with a stroke. Arch Phys Med Rehabil (2011) 1.20
Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression. Psychoneuroendocrinology (2011) 1.19
The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning? Pharmacol Biochem Behav (2010) 1.17
[Temperament and Character Inventory Revised (TCI-R). Standardization and normative data in a general population sample]. Actas Esp Psiquiatr (2004) 1.13
The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. J Pharmacol Exp Ther (2008) 1.12
Cannabinoids and appetite: food craving and food pleasure. Int Rev Psychiatry (2009) 1.11
On measures of explained variance in nonrecursive structural equation models. J Appl Psychol (2000) 1.03
Bioimpedance for severe obesity: comparing research methods for total body water and resting energy expenditure. Obesity (Silver Spring) (2008) 1.02
Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament. Arch Gen Psychiatry (2009) 1.01
Temporal associations between daytime physical activity and sleep in children. PLoS One (2011) 1.00
Lifetime obesity in patients with eating disorders: increasing prevalence, clinical and personality correlates. Eur Eat Disord Rev (2012) 1.00
Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6. Acta Psychiatr Scand (1993) 0.99
The effect of physical activity on weight loss is mediated by eating self-regulation. Patient Educ Couns (2010) 0.98
Synergistic efects of opioid and cannabinoid antagonists on food intake. Psychopharmacology (Berl) (2001) 0.96
Individual sensitivity to pain expectancy is related to differential activation of the hippocampus and amygdala. Hum Brain Mapp (2010) 0.96
Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance. Biol Psychiatry (2012) 0.94
CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis. Exp Neurol (2010) 0.94
Accumulation of short bouts of non-exercise daily physical activity is associated with lower visceral fat in Japanese female adults. Int J Sports Med (2012) 0.93
Cannabinoid CB₂ receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice. Br J Pharmacol (2012) 0.92
Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake. Psychoneuroendocrinology (2013) 0.91
Abdominal obesity, TV-viewing time and prospective declines in physical activity. Prev Med (2011) 0.89
Personality features of obese women in relation to binge eating and night eating. Psychiatry Res (2012) 0.87
Daily physical activity assessment: what is the importance of upper limb movements vs whole body movements? Int J Obes Relat Metab Disord (2004) 0.86
Personality, physical activity, and symptoms of anxiety and depression: the HUNT study. Soc Psychiatry Psychiatr Epidemiol (2012) 0.85
Effects of exercise stress on the endocannabinoid system in humans under field conditions. Eur J Appl Physiol (2011) 0.84
Gender, eating behavior, and personality characteristics in physically active students. Scand J Med Sci Sports (2004) 0.82
Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise. Lipids Health Dis (2011) 0.82
Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism. Addict Biol (2012) 0.81
Physical activity patterns over 10 years in relation to body mass index and waist circumference: the Whitehall II cohort study. Obesity (Silver Spring) (2013) 0.81
ADHD symptomatology in eating disorders: a secondary psychopathological measure of severity? BMC Psychiatry (2013) 0.81
A role for the endocannabinoid system in exercise-induced spatial memory enhancement in mice. Hippocampus (2013) 0.81
Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain Res Bull (2005) 0.81
Comparison of obese and nonobese individuals with binge eating disorder: delicate boundary between binge eating disorder and non-purging bulimia nervosa. Eur Eat Disord Rev (2012) 0.80
The fatty acid amide hydrolase in lymphocytes from sedentary and active subjects. Med Sci Sports Exerc (2014) 0.79
Binge eating and temperament in morbidly obese prebariatric surgery patients. Eur Eat Disord Rev (2011) 0.78
The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity. Obes Rev (2012) 0.78
Intra- and inter-instrument reliability of the actiwatch 4 accelerometer in a mechanical laboratory setting. J Hum Kinet (2012) 0.78
Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome. Psychoneuroendocrinology (2015) 0.77